The New Product Review process formally defines the framework, governance structure, and oversight for the clinical recommendation of new products that support evidence-based outcomes. Combined, this process is one of many we’re embarking on to truly revolutionize veterinary medicine.
The new product review process sets a foundation for the evaluation of new medications and medical products, paving the way for medical recommendations that champion evidence-based outcomes. This process is one of many that we’re embarking on to truly revolutionize veterinary medicine.
The New Product Committee plays a crucial role in shaping the future of medical care within Ethos hospitals. Currently, in Phase 1, the committee is diligently assessing medical literature on new medication requests, with Phase 2 adding a review of medical products on a date to be determined. This committee stands at the forefront of evaluating extensive research data, enabling the creation of internal use guidelines and educational material. These guidelines empower our medical teams to enhance patient outcomes, marking a significant stride towards excellence in healthcare.
Committee Composition
Our New Product Committee is led by the Director of Medical Excellence and is composed of veterinary specialists from our hospitals as well as two veterinary pharmacists.
What we require from you
All of our suppliers are required to complete the following “New Product Request Form” for any new medications that enter the market.